Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-20T12:18:06.876Z Has data issue: false hasContentIssue false
  • English
  • Français

Single oral doses of 13C forms of pteroylmonoglutamic acid and 5-formyltetrahydrofolic acid elicit differences in short-term kinetics of labelled and unlabelled folates in plasma: potential problems in interpretation of folate bioavailability studies

Published online by Cambridge University Press:  09 March 2007

A. J. A. Wright ,
P. M. Finglas ,
J. R. Dainty ,
D. J. Hart ,
C. A. Wolfe ,
S. Southon  and
J. F. Gregory
A. J. A. Wright
Affiliation:
Nutrition Department, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
P. M. Finglas*
Affiliation:
Nutrition Department, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
J. R. Dainty
Affiliation:
Nutrition Department, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
D. J. Hart
Affiliation:
Nutrition Department, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
C. A. Wolfe
Affiliation:
Nutrition Department, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
S. Southon
Affiliation:
Nutrition Department, Institute of Food Research, Norwich Research Park, Colney, Norwich NR4 7UA, UK
J. F. Gregory
Affiliation:
Food Science and Human Nutrition Department, PO Box 110370, University of Florida, Gainesville, FL 32611-0370, USA
*
*Corresponding author: P. M. Finglas, fax +44 1603 507723, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Single 13C6-labelled doses of pteroylmonoglutamic acid (PteGlu; 634 nmol) or 5-formyltetrahydrofolic acid (431–569 nmol) were given to fasted adult volunteers, and the rise in total and 13C-labelled plasma 5-methyltetrahydrofolic acid metabolite monitored over 8 h by HPLC and liquid chromatography–MS. The dose-adjusted area under the curve (AUC) for total (labelled plus unlabelled) plasma 5-methyltetrahydrofolic acid following a 5-formyltetrahydrofolic acid test dose was 155 % that obtained following a PteGlu test dose. Surprisingly, an average 60 and 40 % of the total plasma 5-methyltetrahydrofolic acid response to [13C6]PteGlu and [13C6]5-formyltetrahydrofolic acid, respectively, was unlabelled; an observation never before reported. Short-term kinetics of plasma [13C6]5-methyltetrahydrofolic acid showed a slower initial rate of increase in plasma concentration and longer time to peak following an oral dose of [13C6]PteGlu compared with that for an oral dose of [13C6]5-formyltetrahydrofolic acid, while the [13C6]5-methyltetrahydrofolic acid AUC for [13C6]5-formyltetrahydrofolic acid was 221 % that for [13C6]PteGlu. These data indicate that PteGlu and 5-formyltetrahydrofolic acid, which are thought to be well absorbed (about 90 %) at physiological doses, exhibit dramatically different rates and patterns of plasma response. A limitation in the rate of reduction of PteGlu before methylation could result in slower mucosal transfer of [13C6]5-methyltetrahydrofolic acid derived from [13C6]PteGlu into the plasma. This, when coupled with an observed similar plasma clearance rate for [13C6]5-methyltetrahydrofolic acid metabolite derived from either folate test dose, would yield a comparatively smaller AUC. These findings suggest potential problems in interpretation of absorption studies using unlabelled or labelled folates where the rate of increase, the maximum increase, or the AUC, of plasma folate is employed for test foods (mainly reduced folates) v. a ‘reference dose’ of PteGlu.

Keywords

Pteroylmonoglutamic acidFolateAbsorptionPlasmaStable isotopes
Type
Research Article
Information
British Journal of Nutrition , Volume 90 , Issue 2 , August 2003 , pp. 363 - 371
Copyright
Copyright © The Nutrition Society 2003

References

Anonymous (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131–137.CrossRefGoogle Scholar
Bailey, LB, Barton, LE, Hillier, SE & Cerda, JJ (1988) Bioavailability of mono and polyglutamyl folate in human subjects. Nutr Rep Int 38, 509–518.Google Scholar
Bhandari, SD & Gregory, JF (1992) Folic acid 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in rats. J Nutr 122, 1847–1854.CrossRefGoogle ScholarPubMed
Blakley, RL (1969) The biochemistry of folic acid and related pteridines. In Frontiers of Biology, pp. 92–94. [Neuberger, A and Tatum, EL, editors]. London: North–Holland.Google Scholar
Blount, BC, Mack, MM & Wehr, CM (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 3290–3295.CrossRefGoogle ScholarPubMed
Bousey, CJ, Beresford, SA, Omenn, GS & Motulsky, AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease – probable benefits of increasing folic acid intakes. JAMA 274, 1049–1057.CrossRefGoogle Scholar
Bower, C, Stanley, FJ, Croft, M, De Clerk, NH, Davis, RE & Nicol, DJ (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br J Nutr 69, 827–834.CrossRefGoogle ScholarPubMed
Brown, JP, Scott, JM, Foster, FG & Weir, DG (1973) Ingestion and absorption of naturally occurring pteroylmonoglutamates (folates) in man. Gastroenterology 64, 223–232.CrossRefGoogle ScholarPubMed
Clifford, AJ, Arjomand, A, Dueker, SR, Schneider, PD, Buchholz, BA & Vogel, JS (1998) The dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acid. Adv Exp Med Biol 445, 239–251.CrossRefGoogle Scholar
Czeizel, AE & Dudas, I (1992) Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. N Engl J Med 327, 32–35.CrossRefGoogle Scholar
Fenech, M, Noakes, N, Clifton, P & Topping, D (1999) Aleurone flour is a rich source of bioavailable folate in humans. J Nutr 129, 1114–1119.CrossRefGoogle ScholarPubMed
Finglas, PM, Dainty, JR, Hart, D, Wolfe, C, Wright, AJ, Wright, D, Southon, S & Gregory, JF (2002 a) Modelling of labelled absorbed folates using plasma in humans. FASEB J 16, A748Google Scholar
Finglas, PM, Witthöft, CM, Vahteristo, L et al. (2002) Use of an oral/intravenous dual-label stable-isotope protocol to determine folic acid bioavailability from fortified cereal grain foods in women. J Nutr 132, 936–939.CrossRefGoogle ScholarPubMed
Gregory, JF (1990) Improved synthesis of [3′, 5′-2H2] folic acid: extent and specificity of deuterium labelling. J Agric Food Chem 38, 1073–1076.CrossRefGoogle Scholar
Gregory, JF (1997) Bioavailability of folate. Eur J Clin Nutr 51, Suppl. 1, S54–S59.Google ScholarPubMed
Gregory, JF (2001) Case study: Folate bioavailability. J Nutr 131, Suppl. 4, 1376S–1382S.CrossRefGoogle ScholarPubMed
Gregory, JF, Bhandari, SD, Bailey, LB, Toth, JP, Baumgartner, TG & Cerda, JJ (1992) Relative bioavailability of deuterium-labeled monoglutamyl tetrahydrofolates and folic acid in human subjects. Am J Clin Nutr 55, 1147–1153.CrossRefGoogle ScholarPubMed
Hart, DJ, Finglas, PM, Wolfe, CA, Mellon, F, Wright, AJA & Southon, S (2002) Determination of 5-methyltetrahydrofolate (13C-labelled and unlabelled) in human plasma and urine by combined liquid chromatography mass spectrometry (LC/MS). Anal Biochem 305, 206–213.CrossRefGoogle Scholar
Kelly, P, McPartlin, J, Goggins, M, Weir, DG & Scott, JM (1997) Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 65, 1790–1795.CrossRefGoogle ScholarPubMed
Lucock, MD, Wild, J, Smithells, RW & Hartley, R (1989) In vivo characterization of the absorption and biotransformation of pteroylmonoglutamic acid in man: a model for future studies. Biochem Med Metab Biol 42, 30–42.CrossRefGoogle Scholar
Markkanen, T (1968) Absorption tests with natural folate material in controls and in gastrectomized patients. Am J Clin Nutr 21, 473–481.CrossRefGoogle ScholarPubMed
Mathews, CK & Huennekens, FM (1963) Further studies on dihydrofolate reductase. J Biol Chem 238, 3436–3442.CrossRefGoogle Scholar
Maunder, P, Finglas, PM, Mallet, AI, Mellon, FA, Razzaque, MA, Ridge, B, Vahteristo, L & Witthöft, C (1999) The synthesis of folic acid, multiply labelled with stable isotopes, for bioavailability studies in human nutrition. J Chem Soc Perkin Trans 1, 1311–1323.CrossRefGoogle Scholar
Moran, RG, Keyomasri, K & Colman, PD (1986) Preparation of (6S)-5-formyltetrahydrofolate labelled at high specific activity with 14C- and 2H-. Meth Enzymol 122, 309–313.CrossRefGoogle Scholar
Nephew, KP & Huang, TH-M (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190, 125–133.CrossRefGoogle ScholarPubMed
Perry, J (1971) Folate analogues in normal mixed diets. Br J Nutr 21, 435–441.Google ScholarPubMed
Perry, J & Chanarin, I (1970) Intestinal absorption of reduced folate compounds in man. Br J Haematol 18, 329–339.CrossRefGoogle ScholarPubMed
Perry, J & Chanarin, I (1972) Observations on folate absorption with particular reference to folate polyglutamate and possible inhibitors to its absorption. Gut 13, 544–550.CrossRefGoogle ScholarPubMed
Pietrzik, K, Hages, M & Remer, T (1990) Methodological aspects in vitamin bioavailability testing. J Micronutr Anal 7, 207–222.Google Scholar
Prinz-Langenohl, R, Bronstrup, A, Thorand, B, Hages, M & Pietrzik, K (1999) Availability of food folate in humans. J Nutr 129, 913–916.CrossRefGoogle ScholarPubMed
Rogers, LM, Pfeiffer, CM, Bailey, LB & Gregory, JF (1997) A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability: Evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of [13C5] and [2H2]folic acid. J Nutr 127, 2321–2327.CrossRefGoogle ScholarPubMed
Scott, JM & Weir, DG (1976) Folate composition, synthesis and function in natural materials. Clinics in Haematology 5, 547–568.CrossRefGoogle ScholarPubMed
Seager, H, Aulton, ME & Morton, FSS (1988) Drug delivery systems; soft gelatin capsules. In: Pharmaceutics. The Science of Dosage Form Design, pp. 330–340. [Aulton, ME, editor]. London: Churchill Livingstone.Google Scholar
Selhub, J, Dhar, GJ & Rosenberg, IH (1983) Gastrointestinal absorption of folates and antifolates. Pharmacol Ther 20, 397–418.CrossRefGoogle ScholarPubMed
Shane, B (1995) Folate chemistry and metabolism. In Folate in Health and Disease, pp. 1–22 [Bailey, LB, editor]. New York, NY: Marcel Dekker.Google Scholar
Steinberg, SE, Campbell, CL & Hillman, RS (1979) Kinetics of the normal folate enterohepatic cycle. J Clin Invest 64, 83–88.CrossRefGoogle ScholarPubMed
Van den Berg, H, Finglas, PM & Bates, C (1994) FLAIR Intercomparisons on serum and red cell folate. Int J Vitam Nutr Res 64, 288–293.Google ScholarPubMed
Wolfe, CA, Finglas, PM, Hart, D, Wright, AJA & Southon, S (2001) Isotopic methods to detect food folates. Innovat Food Sci Emerg Technol 1, 297–302.CrossRefGoogle Scholar